Skip to main content
Clinical Trials/KCT0005445
KCT0005445
Recruiting
未知

A prospective, multi-center, observational clinical trial to assess the clinical effectiveness of gastric cancer prognostic prediction molecular diagnosis for patients with pathological stage ? and ? advanced gastric cancer

ovomics0 sites688 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
ovomics
Enrollment
688
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
ovomics

Eligibility Criteria

Inclusion Criteria

  • 1\) Sample providers criteria
  • ? Male and female adult patients aged 19 years or over
  • ? Patients with histologically confirmed gastric adenocarcinoma
  • ? Patients with histologically confirmed stage ? or ?
  • ? Patients who have undergone radical gastrectomy
  • ? Patients who have not received neoadjuvant chemotherapy and radiotherapy
  • ? Patients who have undergone a radical gastrectomy and who show no evidence of residual tumors as observed with the unaided eye or through a microscope
  • ? Patients who have signed a written consent of the study and signed a human derived research agreement (Form 34\)
  • 2\) Sample criteria
  • ? The FFPE tumor specimens in storage have a tumor amount of at least 20% and therefore can be tested.

Exclusion Criteria

  • 1\) Sample providers criteria
  • ? Male and female patients aged less than 19 years
  • ? Patients with histologically not confirmed gastric adenocarcinoma
  • ? Patients with histologically confirmed stage ? or ?
  • ? Patients who have not undergone radical gastrectomy
  • ? Patients who have received neoadjuvant chemotherapy or radiotherapy
  • ? Patients with distant or peritoneal metastasis at the time of surgery or residual tumors after surgery
  • ? Patients who have not signed the study's written consent and human derived research agreement (Form 34\)
  • 2\) Sample criteria
  • ? The FFPE tumor specimens in storage have a tumor amount of less than 20% and therefore cannot be tested

Outcomes

Primary Outcomes

Not specified

Similar Trials